Health Care · In Vitro & In Vivo Diagnostic Substances · Nasdaq · CIK 1850902 · FYE Dec 31 · Prices AT CLOSE 2026-08-27 (USD) Last $7.31 · Day +1.25% · Mkt cap $392M · 1Y +64.3% · Off 52W high −6.8% · Vol (1Y) 79.8% Price2023-08-28 → 2026-08-27 TKNO close: $2.22 on 2023-08-28 to $7.31 on 2026-08-27. Split-adj closes · 240 of 965 · price returnⓘ At a glance | Short interest3.0% of sh out | | Days to cover5.0d | | 13F net flow (QoQ)+2.44% | | Top-10 13F concentration77.8% | | Next report (est.)2026-11-04 |
SI 2026-08-14 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$43.7M | | Earnings (TTM)-$16.8M | | ROE−22.8% | | Net margin−42.6% | | ROIC−21.3% | | Debt / equity0.19× | | Sales growth 3Y−0.7% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+92.4% | | 1Y+64.3% | | 3Y+230.0% | | Since incept. (ann.)+20.3% |
Total return · from 2022-10-18ⓘ Risk | Ann. volatility (1Y)79.8% | | Ann. volatility (3Y)92.1% | | Sharpe (1Y)0.98 | | Sharpe (3Y)0.88 | | Max drawdown (1Y)−68.8% | | Max drawdown (3Y)−79.6% | | Beta (3Y vs SPY)1.11 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Roubaix Capital, LLC | 1.9M | $5M | 3.51% | +88.5% | | ROYCE & ASSOCIATES LP | 1.1M | $3M | 2.00% | +264.2% | | BlackRock, Inc. | 716,774 | $2M | 1.34% | −1.9% | | MILLENNIUM MANAGEMENT LLC | 447,138 | $1M | 0.83% | new | | VANGUARD CAPITAL MANAGEMENT LLC | 441,879 | $1M | 0.82% | new | | UBS Group AG | 325,163 | $939,721 | 0.61% | −55.9% | | Conestoga Capital Advisors, LLC | 317,084 | $916,373 | 0.59% | +0.0% | | GEODE CAPITAL MANAGEMENT, LLC | 307,873 | $889,996 | 0.57% | +7.1% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-05 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-05 | −$0.06 | — | $12.2M | +18.5% | | 2026-03-31 | 2026-05-06 | −$0.08 | — | $11.1M | +13.1% | | 2025-12-31 | 2026-02-26 | −$0.08 | — | $10.0M | +7.8% | | 2025-09-30 | 2025-11-06 | −$0.08 | — | $10.5M | +9.2% |
As-reported XBRL · next 2026-11-04 est.ⓘ Segment mixFY2025 (ended Dec 2025) US 94% · Non Us 6% geographic · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
